Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 149Breast Neoplasms 38Prostatic Neoplasms 31Insulin Resistance 30Obesity 23Endometrial Neoplasms 15Neoplasms 14Infertility 14Colorectal Neoplasms 13Pancreatic Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Anovulation 10Lung Neoplasms 9Neoplasm Metastasis 8Hyperandrogenism 8Glioblastoma 8Diabetes Mellitus 8Squamous Cell Carcinoma of Head and Neck 7Metabolic Syndrome 7Melanoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Ovarian Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Head and Neck Neoplasms 5Brain Neoplasms 5Adenocarcinoma 5Weight Loss 4Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Rectal Neoplasms 4

Interventions

Metformin 2Utrogestan 1Timolol 1Tablets 1Self Care 1Population Groups 1Kangaroo-Mother Care Method 1Inositol 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Premature Birth × Metformin × Clear all
NCT01587378 2019-02-26

PregMet2

Norwegian University of Science and Technology

Phase NA Completed
489 enrolled

Abortion, Spontaneous, Polycystic Ovary Syndrome, Premature Birth

NCT00159536 2019-02-15

PregMet

Norwegian University of Science and Technology

Phase 3 Completed
257 enrolled

Diabetes Mellitus, Polycystic Ovary Syndrome, Pre-Eclampsia, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡